Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells
- PMID: 1661312
Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells
Abstract
The expression of TNF-alpha receptors (TNFR) was examined on a CD4+ T cell hybridoma, transformed T cell lines, CTL clones, and activated T cells from peripheral blood to determine the basis of the immunomodulatory activity of TNF on T cell function. Analyses by ligand cross-linking and competitive binding assays with mAb to the 80-kDa receptor (TNFR-I), demonstrated that the TNFR-I was the predominant receptor expressed on activated CD4+ and CD8+ T cell subsets. However, on T cell leukemic lines, a second, non-TNFR-I binding site was identified, most likely the 55-kDa form (TNFR-II). Additional subsets of T cells were readily distinguished by their expression of TNFR-I and related members of the TNFR gene family (CD40 and CD27). Expression of the TNFR-I was dependent upon the state of T cell activation. Signaling through the TCR for Ag or IL-2R was sufficient to induce TNFR mRNA and protein expression in resting T cells. Multiple sizes of TNFR-I transcripts were detected during T cell activation; however, biosynthetic studies showed these multiple species encode a single protein of 80 kDa. These results, combined with the known ability of TNF to induce IL-2R expression, indicate that TNF and IL-2 form a reciprocating receptor amplification circuit. In contrast, differentiated effector T cells triggered through the TCR or protein kinase C initiated a rapid down-regulation (transmodulation) of the TNFR-I that preceded TNF or lymphotoxin secretion. The mechanism of transmodulation involved proteolytic processing of the mature 80-kDa receptor releasing a soluble 40-kDa fragment. This indicates that a TNF autocrine loop is not likely to form during the response of an effector T cell. Collectively, these results suggest that transcriptional and post-translational modification of the TNFR-I are important control points regulating the expression of this receptor during T cell activation.
Similar articles
-
Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes.Eur J Immunol. 1991 Apr;21(4):1033-7. doi: 10.1002/eji.1830210426. Eur J Immunol. 1991. PMID: 1850359
-
Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.J Immunol. 1991 Mar 1;146(5):1522-6. J Immunol. 1991. PMID: 1847164
-
Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.J Immunol. 1990 Apr 1;144(7):2582-91. J Immunol. 1990. PMID: 1969453
-
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.Blood. 1995 Jun 15;85(12):3378-404. Blood. 1995. PMID: 7780126 Review.
-
The TNF-TNFR Family of Co-signal Molecules.Adv Exp Med Biol. 2019;1189:53-84. doi: 10.1007/978-981-32-9717-3_3. Adv Exp Med Biol. 2019. PMID: 31758531 Review.
Cited by
-
The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.Surg Today. 1994;24(3):197-202. doi: 10.1007/BF02032887. Surg Today. 1994. PMID: 8003860 Review.
-
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.Nat Rev Rheumatol. 2009 Oct;5(10):578-82. doi: 10.1038/nrrheum.2009.181. Nat Rev Rheumatol. 2009. PMID: 19798034 Review.
-
Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death.Theranostics. 2020 Mar 15;10(10):4481-4489. doi: 10.7150/thno.41646. eCollection 2020. Theranostics. 2020. PMID: 32292509 Free PMC article.
-
Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.Scand J Rheumatol. 2017 Jul;46(4):263-272. doi: 10.1080/03009742.2016.1231339. Epub 2016 Dec 15. Scand J Rheumatol. 2017. PMID: 27973968 Free PMC article.
-
Re-Examining the Role of TNF in MS Pathogenesis and Therapy.Cells. 2020 Oct 14;9(10):2290. doi: 10.3390/cells9102290. Cells. 2020. PMID: 33066433 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials